Double-Crossed: Why Crossover in Clinical Trials May Be Distorting Medical Science-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Double-Crossed: Why Crossover in Clinical Trials May Be Distorting Medical Science

Published:2013-05 Issue:5 Volume:11 Page:625-627
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:en
Short-container-title:J Natl Compr Canc Netw

Author:

Prasad Vinay

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Enrollment per Month (Accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs;Targeted Oncology;2024-07-31

2. Validation of overall survival extrapolations made by TLV in the assessment of cost-effectiveness of oncology drugs in Sweden – A pilot study comparing extrapolated and observed life-years gained;Journal of Medical Economics;2024-01-29

3. Trends in the crossover of patients in phase III oncology clinical trials in the USA;ecancermedicalscience;2020-11-13

4. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials;European Journal of Cancer;2020-09

5. Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration;JAMA Internal Medicine;2020-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP